FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Sealant, Dural
PMA: P220014
·
Supplement: S002
·
Decision Dec 20, 2023
Classifications
1
FEI Numbers
13
Registration Numbers
13
Basic Information
- Device Name
- Sealant, Dural
- Trade Name
- CraniSeal Dural Sealant
- PMA Number
- P220014
- Supplement Number
- S002
- Device Class
- FDA Class 3
- Product Code
- NQR
- Generic Name
- Sealant, dural
- Medical Specialty
- Unknown
- Advisory Committee
- Neurology
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- December 20, 2023
- Date Received
- November 21, 2023
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
a change to improve the repeatability of a quality control test method for the CraniSeal precursors
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NQR | Sealant, Dural | FDA class 3 | Unknown |